Psoriasis Clinical Trial
A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting
Summary
The purpose of this study is to evaluate the effect of deucravacitinib on quality of life (QoL) in participants with plaque psoriasis in a community setting.
Eligibility Criteria
Inclusion Criteria
Men and women diagnosed with stable plaque psoriasis for 6 months or more. Stable psoriasis is defined as no morphology changes or significant flares of disease activity in the opinion of the investigator.
Deemed by the investigator to be a candidate for phototherapy or systemic therapy.
≥ 3% of Body Surface Area (BSA) involvement at the Screening Visit and Day 1
Dermatology Life Quality Index (DLQI) score > 5 at the Screening Visit and Day 1
Moderate-to-severe plaque psoriasis as defined by static Physician Global Assessment (s-PGA) ≥ 3 at the Screening Visit and Day 1
Exclusion Criteria:
Target Disease Exceptions:
Non-plaque psoriasis (that is, guttate, pustular, erythrodermic, palmoplantar only involvement or drug-induced psoriasis) at Screening Visit or Day 1
Other protocol-defined inclusion/exclusion criteria apply.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 39 Locations for this study
Phoenix Arizona, 85006, United States
Scottsdale Arizona, 85260, United States
North Little Rock Arkansas, 72117, United States
Bakersfield California, 93309, United States
Sacramento California, 95815, United States
San Diego California, 92103, United States
Centennial Colorado, 80111, United States
Washington District of Columbia, 20016, United States
Brandon Florida, 33511, United States
Coral Gables Florida, 33134, United States
Pembroke Pines Florida, 33028, United States
Atlanta Georgia, 30331, United States
Snellville Georgia, 30078, United States
Rolling Meadows Illinois, 60008, United States
Skokie Illinois, 60077, United States
Springfield Illinois, 62703, United States
Baton Rouge Louisiana, 70809, United States
Rockville Maryland, 20850, United States
Auburn Hills Michigan, 48326, United States
Waterford Michigan, 48328, United States
Las Vegas Nevada, 89148, United States
Reno Nevada, 89509, United States
New York New York, 10011, United States
New York New York, 10128, United States
Rochester New York, 14623, United States
Bexley Ohio, 43209, United States
Mayfield Heights Ohio, 44124, United States
Sugarloaf Pennsylvania, 18249, United States
Charleston South Carolina, 29407, United States
Cypress Texas, 77433, United States
Frisco Texas, 75034, United States
South Jordan Utah, 84095, United States
Springville Utah, 84663, United States
Bellevue Washington, 98004, United States
Mill Creek Washington, 98012, United States
Spokane Washington, 99202, United States
Caguas , 00727, Puerto Rico
Carolina , 00985, Puerto Rico
San Juan , 00917, Puerto Rico
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.